AM
AIGEA Medical develops proprietary generative AI algorithms, DeepMammo, to support digital imaging workflows for breast cancer diagnosis. This technology increases radiologist performance by automating repetitive tasks, thereby enhancing diagnostic accuracy and reducing daily workloads. The platform optimizes triage and speeds up cancer diagnosis, leading to shorter screening times.
Updated 1 month ago
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
I
Funding rounds are not available yet.
Founders
Product
Features
- AIGEA Medical develops proprietary generative AI algorithms, DeepMammo, to support digital imaging workflows for breast cancer diagnosis. This technology increases radiologist performance by automating repetitive tasks, thereby enhancing diagnostic accuracy and reducing daily workloads. The platform optimizes triage and speeds up cancer diagnosis, leading to shorter screening times.